ALS Automated Lab Solutions GmbH
Operation name
2019 FE 0131
2019 FE 0131
Operation summary
Development and validation of a high-throughput process for single-cell cloning of genetically modified mammalian cells for the production of biopharmaceutically applicable production cell lines with the aid of a novel technology platform (FastClone)
Development and validation of a high-throughput process for single-cell cloning of genetically modified mammalian cells for the production of biopharmaceutically applicable production cell lines with the aid of a novel technology platform (FastClone)
Operation start date
03.07.2020
03.07.2020
Operation end date
31.12.2022
31.12.2022
Total eligible expenditure allocated to the operation
1.645.250,00
1.645.250,00
Union co-financing rate
80 %
80 %
Operation postcode
07745
07745
Country
Deutschland
Deutschland
Name of category of intervention
064 - Research and innovation processes in SMEs (including voucher programmes, innovations in the areas of operations, design, and service, as well as social innovations)
064 - Research and innovation processes in SMEs (including voucher programmes, innovations in the areas of operations, design, and service, as well as social innovations)
